Finance

Lists
4506:TYO
Sumitomo Pharma Co Ltd
¥1,933.50
-1.98%
(-39.00) 1D
Nov 4, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4506...
Open
¥1,932
High
¥1,954
Low
¥1,874
Mkt. cap
868.54B
Avg. vol.
4.07M
Volume
4.76M
P/E ratio
18.15
52-wk high
¥3,288
52-wk low
¥1,188
EPS
¥107
Shares outstanding
397.30M
No. of employees
3K
Open
¥1,932
High
¥1,954
Low
¥1,874
Mkt. cap
868.54B
Avg. vol.
4.07M
Volume
4.76M
P/E ratio
18.15
52-wk high
¥3,288
52-wk low
¥1,188
EPS
¥107
Shares outstanding
397.30M
No. of employees
3K
News stories
From web sources and news partners
Profile
Sumitomo Pharma Company Limited is a Japanese multinational pharmaceutical company. The company is focused on oncology, psychiatry, neurology, women's health issues, urological diseases among other areas. Its headquarters are located in Chuo-ku, Osaka. Wikipedia
About Sumitomo Pharma Co Ltd
CEO-
Employees3.12K
FoundedMay 14, 1897
HeadquartersOsaka, Osaka, Japan
SectorPharmaceutical industry
Industry-
Last report
Oct 30, 2026
Fiscal period
Q2 2027
- / -
Revenue / Est. (JPY)
137.00B / 126.60B
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
120.62B
105.55B
129.50B
137.00B
Cost of goods sold
55.44B
51.26B
61.41B
62.11B
Cost of revenue
55.44B
51.26B
61.41B
62.11B
Research and development expenses
10.35B
16.12B
11.43B
12.33B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
42.94B
43.52B
39.24B
39.48B
Operating expense
52.19B
110.09B
50.33B
51.59B
Total operating expenses
107.63B
161.36B
111.74B
113.70B
Operating income
13.00B
-55.81B
17.75B
23.29B
Other non operating income
-
-1.64B
-
-
EBT including unusual items
8.74B
-1.20B
18.30B
21.09B
EBT excluding unusual items
8.74B
-51.00B
18.30B
21.09B
Income tax expense
-80.00M
-383.00M
1.30B
-154.00M
Effective tax rate
-0.92%
32.05%
7.09%
-0.73%
Other operating expenses
-1.10B
50.45B
-337.00M
-212.00M
Net income
8.82B
-812.00M
17.00B
21.24B
Net profit margin
7.31%
-0.77%
13.13%
15.50%
Earnings per share
-
-
-
-
Interest and investment income
258.00M
4.64B
2.20B
-
Interest expense
-5.14B
-
-2.09B
-3.00B
Net interest expenses
-4.88B
4.64B
107.00M
-3.00B
Depreciation and amortization charges
-
-
-
-
EBITDA
18.32B
-52.48B
22.65B
28.17B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps